Unknown

Dataset Information

0

Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers.


ABSTRACT: Epigenetic modifiers acting through polypharmacology mechanisms are promising compounds with which to treat several infectious diseases. Histone deacetylase (HDAC) enzymes, mainly class I, and extra-terminal bromodomains (BET) are involved in viral replication and the host response. In the present study, 10 compounds were designed, assisted by molecular docking, to act against HDAC class I and bromodomain-4 (BRD4). All the compounds were synthesized and characterized by analytical methods. Enzymatic assays were performed using HDAC-1, -4, and -11 and BRD4. Compounds (2-10) inhibited both HDAC class I, mainly HDAC-1 and -2, and reduced BRD4 activity. For HDAC-1, the inhibitory effect ranged from 8 to 95%, and for HDAC-2, these values ranged from 10 to 91%. Compounds (2-10) decreased the BRD4 activity by up to 25%. The multi-target effects of these compounds show desirable properties that could help to combat viral infections by acting through epigenetic mechanisms.

SUBMITTER: Lopes JR 

PROVIDER: S-EPMC8709175 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9174839 | biostudies-literature
| S-EPMC9257310 | biostudies-literature
| S-EPMC4862508 | biostudies-literature
| S-EPMC4027494 | biostudies-literature
| S-EPMC2849109 | biostudies-literature
| S-EPMC7793533 | biostudies-literature
| S-EPMC10420662 | biostudies-literature
| S-EPMC6930559 | biostudies-literature
| S-EPMC7204524 | biostudies-literature
| S-EPMC2714055 | biostudies-literature